Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026

Fortrea (FTRE)

Nasdaq Health Care Biotechnology S&P SmallCap 600
$21.96
+1.50 (+7.33%)
Close of Nov 06, 2026 · end-of-day data
Source: Fortrea's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2021FY2022FY2023FY2024FY2025
Revenue$3.06B$2.84B$2.84B$2.70B$2.72B
Cost of revenue$2.45B$2.11B$2.25B$2.16B$2.22B
Gross profit$604.40M$724.40M$590.60M$534.20M$503.80M
Selling, general & admin$303.10M$416.10M$448.10M$560.70M$456.40M
Operating income$114.30M$187.10M$32.00M-$161.90M-$872.60M
Interest expense$200.00K$200.00K$69.80M——
Pre-tax income$136.40M$187.00M-$30.50M-$275.00M-$983.00M
Income tax$38.40M$41.10M$1.20M-$3.50M$3.20M
Net income$98.00M$186.20M-$25.20M-$328.50M-$986.20M
EBITDA$280.60M$280.70M$130.00M-$75.00M-$794.60M
EPS (basic)$1.10$2.09$-0.29$-3.67$-10.81
EPS (diluted)$1.10$2.09$-0.29$-3.67$-10.81
Diluted shares88.80M88.80M88.80M89.50M—
Gross margin19.8%25.5%20.8%19.8%18.5%
Operating margin3.7%6.6%1.1%-6.0%-32.0%
Net margin3.2%6.6%-0.9%-12.2%-36.2%

Balance sheet

fiscal years · USD
Fiscal yearFY2021FY2022FY2023FY2024FY2025
Cash & equivalents$94.60M$112.00M$108.60M$118.50M$174.60M
Total current assets—$1.25B$1.25B$948.20M$897.20M
Goodwill$2.08B$1.71B$1.74B$1.71B$960.00M
Total assets—$4.29B$4.33B$3.58B$2.72B
Total current liabilities—$699.00M$778.40M$949.50M$913.30M
Short-term debt—$0$26.10M$74.80M$4.80M
Long-term debt—$0$1.57B$1.05B$1.05B
Total debt—$0$1.59B$1.12B$1.05B
Total liabilities—$945.30M$2.62B$2.22B$2.15B
Shareholders' equity$3.26B$3.34B$1.71B$1.36B$563.50M

Cash flow

fiscal years · USD
Fiscal yearFY2021FY2022FY2023FY2024FY2025
Operating cash flow$169.80M$82.70M$168.40M$262.80M$113.50M
Capital expenditures$26.50M$54.40M$40.30M$25.50M$25.20M
Free cash flow$143.30M$28.30M$128.10M$237.30M$88.30M
Investing cash flow-$26.20M-$54.00M-$31.80M$251.60M$14.40M
Financing cash flow-$128.50M-$6.30M-$140.80M-$497.80M-$76.30M
Stock-based compensation$27.50M$25.40M$42.70M$58.40M$74.40M
Depreciation & amortization$166.30M$93.60M$98.00M$86.90M$78.00M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.